Inflation Reduction Act (IRA) Educational Resources

August 21, 2024

Medicare

As a means of providing additional support to our clients, the following videos and companion guides have been created to provide education and awareness to agent/brokers and customer service. This content is designed to be an educational resource for these key stakeholders to highlight recent and upcoming changes to the Medicare Part D program.

This includes the following (target audience noted for each):

Customer Service Educational Resources
  • M3P Customer Service Video and companion user guide – the video and user guide provide information about the M3P program, including CSP (Customer Service Platform) screen shots and procedures on how to support members calling in about the M3P program.  https://bcove.video/3SuKQE9
  • IRA Educational document can be used as an educational resource to highlight upcoming changes to the Medicare Part D benefit effective 1/1/2025, including M3P. This document can be used for customer service and agent/broker.
Medicare Agent/Broker Educational Resources
  • M3P Agent/Broker Video and companion user guide provides information about the M3P program. https://bcove.video/3LII9L9
  • Medicare Educational document is an educational resource for these key stakeholders to highlight recent and upcoming changes to Medicare Part D and can be easily copied and pasted into your own educational materials.
    • Topics include:
      • Insulin Cost Share Caps
      • Out of Pocket Maximums
      • Supplemental Benefits
      • Weight Loss Drugs
      • Biosimilars
      • Dual Special Needs Plans (DSNP)
      • Medicare-Medicaid Plans (MMP)
      • Prescription Drug Plans (PDP)
      • Medigap/Medicare Supplement

Click here for more information on the IRA including background and likely to benefit

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

You may also like

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

legislation

Illinois enacts new AI security law

Illinois recently enacted the Artificial Intelligence (AI) Safety Measures Act to implement new security and reporting requirements for developers of the largest frontier AI models. The law requires covered developers to assess and mitigate catastrophic risks, report significant safety incidents within 72 hours, and undergo independent third-party audits beginning in 2028. The law was modeled […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

legislation

Delaware strengthens primary care spending

As part of his affordability agenda, Gov. Matt Meyer (D) signed legislation to make permanent a requirement on insurers to spend at least a minimum level on primary care. The primary care services measure, SB 1, will establish minimum primary care spending for carriers, with the state monitoring the uptake and compliance program. The bill […]
read more >

August 11, 2026

marketplace medicaid